Skip to content

Clinical trials

Phase 2 Hidradenitis Suppurativa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hidradenitis Suppurativa Phase: Phase 2 Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20121
20131
20151
20162
20171
20185
20195
20204
20217
20226
20234
20244
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting10
Terminated9
Active, not recruiting4
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Incyte Corporation4
Janssen Research & Development, LLC4
Sanofi4
Beth Israel Deaconess Medical Center3
Florida Academic Dermatology Centers3
Boehringer Ingelheim2
Eli Lilly and Company2
InflaRx GmbH2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hidradenitis Suppurativa60
Hidradenitis7
Skin Diseases7
Sweat Gland Diseases3
Abscess2
Dermatitis2
Dermatitis, Atopic2
Inflammation2
Skin Diseases, Bacterial2
Acne Vulgaris1

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.